Annual SG&A
$58.09 M
+$15.70 M+37.03%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual selling, general & administrative expenses is currently $58.09 million, with the most recent change of +$15.70 million (+37.03%) on 31 December 2023. During the last 3 years, it has risen by +$40.07 million (+222.28%). CRNX annual SG&A is now at all-time high.CRNX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$25.89 M
+$1.05 M+4.24%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly selling, general & administrative expenses is currently $25.89 million, with the most recent change of +$1.05 million (+4.24%) on 30 September 2024. Over the past year, it has increased by +$10.41 million (+67.22%). CRNX quarterly SG&A is now at all-time high.CRNX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.04 B
-$277.91 M-10.06%
30 September 2024
Summary:
Crinetics Pharmaceuticals TTM selling, general & administrative expenses is currently -$3.04 billion, with the most recent change of -$277.91 million (-10.06%) on 30 September 2024. Over the past year, it has dropped by -$3.09 billion (-5914.76%). CRNX TTM SG&A is now -18593.74% below its all-time high of $88.64 million, reached on 30 September 2024.CRNX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.0% | +67.2% | -5914.8% |
| 3 y3 years | +222.3% | +315.8% | -10000.0% |
| 5 y5 years | +772.4% | +562.0% | -10000.0% |
CRNX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +222.3% | at high | +315.8% | -271.2% | at low |
| 5 y | 5 years | at high | +772.4% | at high | +663.3% | -1167.7% | at low |
| alltime | all time | at high | +3689.6% | at high | +6505.1% | <-9999.0% | at low |
Crinetics Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $25.89 M(+4.2%) | $88.64 M(+13.3%) |
| June 2024 | - | $24.84 M(+19.3%) | $78.23 M(+17.2%) |
| Mar 2024 | - | $20.83 M(+22.0%) | $66.73 M(+14.9%) |
| Dec 2023 | $58.09 M(+37.0%) | $17.08 M(+10.3%) | $58.09 M(+11.1%) |
| Sept 2023 | - | $15.48 M(+16.0%) | $52.29 M(+7.3%) |
| June 2023 | - | $13.34 M(+9.5%) | $48.73 M(+6.2%) |
| Mar 2023 | - | $12.19 M(+8.1%) | $45.88 M(+8.2%) |
| Dec 2022 | $42.39 M(+72.9%) | $11.27 M(-5.5%) | $42.39 M(+10.2%) |
| Sept 2022 | - | $11.93 M(+13.7%) | $38.48 M(+17.4%) |
| June 2022 | - | $10.49 M(+20.5%) | $32.78 M(+17.5%) |
| Mar 2022 | - | $8.71 M(+18.3%) | $27.90 M(+13.7%) |
| Dec 2021 | $24.52 M(+36.1%) | $7.36 M(+18.2%) | $24.52 M(+10.9%) |
| Sept 2021 | - | $6.23 M(+11.2%) | $22.12 M(+7.1%) |
| June 2021 | - | $5.60 M(+5.0%) | $20.65 M(+6.6%) |
| Mar 2021 | - | $5.33 M(+7.5%) | $19.37 M(+7.5%) |
| Dec 2020 | $18.03 M | $4.96 M(+4.4%) | $18.03 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $4.75 M(+9.9%) | $16.46 M(+5.4%) |
| June 2020 | - | $4.32 M(+8.3%) | $15.62 M(+8.8%) |
| Mar 2020 | - | $3.99 M(+17.7%) | $14.35 M(+6.2%) |
| Dec 2019 | $13.52 M(+103.0%) | $3.39 M(-13.3%) | $13.52 M(+6.5%) |
| Sept 2019 | - | $3.91 M(+27.8%) | $12.69 M(+20.7%) |
| June 2019 | - | $3.06 M(-3.0%) | $10.51 M(+22.7%) |
| Mar 2019 | - | $3.16 M(+23.2%) | $8.57 M(+28.7%) |
| Dec 2018 | $6.66 M(+243.4%) | $2.56 M(+47.9%) | $6.66 M(+45.9%) |
| Sept 2018 | - | $1.73 M(+54.9%) | $4.57 M(+37.3%) |
| June 2018 | - | $1.12 M(-10.4%) | $3.32 M(+27.9%) |
| Mar 2018 | - | $1.25 M(+167.2%) | $2.60 M(+34.0%) |
| Dec 2017 | $1.94 M(+26.5%) | $467.00 K(-4.9%) | $1.94 M(+31.7%) |
| Sept 2017 | - | $491.00 K(+25.3%) | $1.47 M(+50.1%) |
| June 2017 | - | $392.00 K(-33.4%) | $981.00 K(+66.6%) |
| Mar 2017 | - | $589.00 K | $589.00 K |
| Dec 2016 | $1.53 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual SG&A year-on-year change?
- What is Crinetics Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly SG&A year-on-year change?
- What is Crinetics Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM SG&A year-on-year change?
What is Crinetics Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of CRNX is $58.09 M
What is the all time high annual SG&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual selling, general & administrative expenses is $58.09 M
What is Crinetics Pharmaceuticals annual SG&A year-on-year change?
Over the past year, CRNX annual selling, general & administrative expenses has changed by +$15.70 M (+37.03%)
What is Crinetics Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of CRNX is $25.89 M
What is the all time high quarterly SG&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $25.89 M
What is Crinetics Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, CRNX quarterly selling, general & administrative expenses has changed by +$10.41 M (+67.22%)
What is Crinetics Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of CRNX is -$3.04 B
What is the all time high TTM SG&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM selling, general & administrative expenses is $88.64 M
What is Crinetics Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, CRNX TTM selling, general & administrative expenses has changed by -$3.09 B (-5914.76%)